Status:
UNKNOWN
Safety of Tranexamic Acid in Reducing Blood Loss Myomectomy.
Lead Sponsor:
Aljazeera Hospital
Collaborating Sponsors:
Cairo University
Conditions:
Myoma
Eligibility:
FEMALE
20-50 years
Phase:
NA
Brief Summary
Uterine leiomyomas (fibroids) are the most common benign tumors among women . Fibroids are found in approximately 15% to 30% of women in the reproductive age group
Detailed Description
Although most of them are asymptomatic, 20-50% of fibroids may cause problems such as heavy menstrual bleeding, anemia, pelvic pain, pressure symptoms from extrinsic compression of the colorectal and ...
Eligibility Criteria
Inclusion
- women with myomas
Exclusion
- with with malignant lesions
Key Trial Info
Start Date :
January 10 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 10 2021
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04694677
Start Date
January 10 2021
End Date
September 10 2021
Last Update
January 5 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Algazeerah
Giza, Egypt